Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

NCT03087890 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

537

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection
Pneumocystis Pneumonia
Opportunistic Infections
Preventive Therapy
Antibiotic Side Effect

Interventions

DRUG: Cotrimoxazole
DRUG: Placebo

Sponsor

University of Bergen

Collaborators

[object Object]
[object Object]
[object Object]